Reaction
Tinea Pedis reporting signals
As of the last recalculation, Tinea Pedis appears in 1,577 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is TERBINAFINE HYDROCHLORIDE (PRR 36.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Terbinafine Hydrochloride | 24 | 36.2 | 36.3 |
| Ketoconazole Cream, 2% | 27 | 24.4 | 24.5 |
| Ketoconazole Foam | 24 | 21.7 | 21.8 |
| Ketoconazole | 27 | 20.9 | 21.0 |
| Insulin Glulisine | 15 | 19.6 | 19.7 |
| Dimenhydrinate | 15 | 18.7 | 18.8 |
| Dolutegravir Sodium | 11 | 16.2 | 16.2 |
| Cefazolin Sodium | 14 | 15.5 | 15.5 |
| Clotrimazole | 14 | 15.2 | 15.2 |
| Baricitinib | 11 | 15.2 | 15.2 |
| Cefazolin | 10 | 14.6 | 14.6 |
| Tolterodine Tartrate | 9 | 13.3 | 13.3 |
| Pramipexole | 15 | 13.0 | 13.0 |
| Bimekizumab | 20 | 12.5 | 12.6 |
| Miconazole Nitrate | 7 | 10.6 | 10.6 |
| Drs. Clotrimazole | 9 | 10.3 | 10.3 |
| Family Wellness Clotrimazole | 9 | 10.3 | 10.3 |
| Clotrimazole Topical | 9 | 10.3 | 10.3 |
| Secukinumab | 117 | 10.3 | 10.3 |
| Ixekizumab | 28 | 10.2 | 10.2 |
| Emtricitabine And Tenofovir Alafenamide | 8 | 9.4 | 9.4 |
| Tramadol Hydrochloride | 24 | 8.5 | 8.5 |
| Pitavastatin Calcium | 6 | 7.8 | 7.8 |
| Ocrelizumab | 34 | 7.4 | 7.4 |
| Nevirapine | 5 | 7.3 | 7.3 |
| Lisdexamfetamine Dimesylate | 18 | 7.3 | 7.3 |
| Fingolimod Hcl | 35 | 5.4 | 5.4 |
| Dofetilide | 4 | 5.0 | 5.0 |
| Pseudoephedrine Hcl | 4 | 4.8 | 4.8 |
| Cabozantinib | 14 | 3.9 | 3.9 |
| Pseudoephedrine Hydrochloride | 3 | 3.9 | 3.9 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 5 | 3.7 | 3.7 |